FINGOLIMOD
NDC 82009-143, FINGOLIMOD, capsule, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-143
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207979
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-143 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FINGOLIMOD HYDROCHLORIDE.5 mg/1
Pharmacologic classes
Sphingosine 1-Phosphate Receptor Modulators [MoA]; Sphingosine 1-phosphate Receptor Modulator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-143-30 | 82009014330 | 30 CAPSULE in 1 BOTTLE (82009-143-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5434bd4a-2610-0e17-4f14-513ff1cbb822NADAC price for package 82009014330
GET /v1/drugs/nadac/82009014330
Use it
Look up 82009-143 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-143 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-143. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.